The AnapnoGuard solution provides the clinical staff with the tools to minimize complications while maintaining the highest standards of care in intubated and ventilated patients.
It consists of a platform of automated as well as disposable devices.
The AnapnoGuard Solution
Automated ET Tube Cuff Pressure Control
Cuff pressure management, provided by the AnapnoGuard solution, ensures tracheal sealing at the minimum cuff pressure. Appropriate sealing of the trachea, allows for positive pressure ventilation while minimizing aspiration of subglottic secretions and diminishing the likelihood of tracheal tissue injuries, such as mucosal edema, ulceration, fistula, granulomas and injuries to the vocal cords.
The AnapnoGuard solution monitors air leakage from the lungs around the airway cuff, based on continuous measurement of CO2 levels in the subglottic space, above the cuff. High levels of CO2 above the cuff indicate leakage. Therefore, if the system detects a rise in CO2 level above the cuff, it increases the cuff pressure to the minimal pressure needed to ensure tracheal sealing. If no leak is detected, the system decreases the cuff pressure over time, as long as sealing is maintained. The cuff pressure is adjusted within a pressure range that has been predetermined by the clinician.
If the AnapnoGuard AG100s control unit is not available, easy monitoring and adjustment of the ET Tube cuff pressure can be achieved with the manual digital manometer, the AG Cuffill.
Effective Evacuation of Subglottic Secretions
The AnapnoGuard solution is designed to ensure effective sealing of the trachea at minimal cuff pressure, while effectively evacuating the subglottic secretions. These functions reduce pulmonary aspiration of subglottic secretions which are known to be a significant contributor to the development of Ventilator-Associated Pneumonia (VAP) and Ventilator-Associated Respiratory Infection (VARI).
The AnapnoGuard ET Tube, comprising of three unique lumens, in conjunction with the AnapnoGuard AG100s control unit, allows simultaneous subglottic rinsing or venting and evacuation of subglottic secretions.
In clinical settings, where the AnapnoGuard AG100s control unit is not available, effective rinsing and suction of the subglottic secretions can be achieved manually with the single-use AG MASS device.
The AnapnoGuard solution consists of the following products:
AG100s Control Unit
The Heart of Advanced Airway Management
The AnapnoGuard AG100s Control Unit serves as an integrated, multi-purpose airway management system, highly effective in protecting the lungs and tracheal tissues from infections and tissue injury.
STANDARDIZATION OF CLINICAL CARE
By automated implementation of clinical guidelines.
By rinsing and evacuation of subglottic secretions and preventing tracheal injury
By controlling cuff pressure to fit patient conditions
By reduction of complications, leading to shorter hospitalization
AUTOMATED, CLOSED LOOP CUFF PRESSURE CONTROL
REAL-TIME LEAKAGE DETECTION BY MONITORING CO2 LEVEL ABOVE THE CUFF
AND EVACUATION OF SUBGLOTTIC SECRETIONS
DEEP SUCTION AND ORAL SUCTION
SUPPORTING SUCTION AND STANDARD AIRWAYS
When combined with the innovative AG ET Tube, the AnapnoGuard AG100s Control Unit provides effective and advanced cuff pressure control by continuous monitoring of CO2 leaks around and above the tracheal cuff.
When CO2 leakage is detected, the AnapnoGuard AG100s Control Unit automatically adjusts the cuff pressure to ensure trachea sealing at the lowest possible pressure.
In addition, the AnapnoGuard AG100s Control Unit provides effective evacuation of subglottic secretions by intermittent and simultaneous rinsing and suction of these secretions.
It is also equipped with a dedicated suction port that allows for automated preset intermittent oral suction, as well as advanced lung suction.
The AnapnoGuard AG100s Control Unit is compatible with all Standard and Suction Airways.
When connected to a Standard ET tube, the AnapnoGuard AG100s Control Unit provides automated fixed cuff pressure.
When connected to a Suction ET tube, the AnapnoGuard AG100s Control Unit also provides intermittent suction of subglottic secretions.
The AnapnoGuard AG100s Control Unit provides a comprehensive airway management solution, aimed at minimizing the risks and promoting better treatment outcomes in mechanically ventilated patients.
US FDA 510(k) | European CE Mark | China CFDA